Home / Recalls / Medical Devices
Phadia US Inc recalls ImmunoCAP Allergen c6, Amoxicilloyl ( Article number 14-4451-016). ImmunoCAP Specific IgE is an in vitro quantitative
Recalled April 11, 2018 · FDA recall Z-1313-2018 · Phadia US
Hazard
The stability specifications of ImmunoCAP Allergen c6, Amoxicilloyl were not met. · FDA Class II
Units
950 total
Sold at
Nationwide Distribution
Description
The stability specifications of ImmunoCAP Allergen c6, Amoxicilloyl were not met.
Product
ImmunoCAP Allergen c6, Amoxicilloyl ( Article number 14-4451-016). ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human serum or plasma; to be used with the instrument Phadia 250, Phadia 1000, Phadia 2500 and Phadia 5000.
Manufacturer(s)
Phadia US Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →